Dr. Nghiem has over 170 publications that have been cited 10,907 times as of August 5, 2019, with an h-index of 54 and an i10-index of 122 according to Google Scholar.
Heath, M; Jaimes, N; Lemos, B; Mostaghimi, A; Wang, L C; Peñas, P F; Nghiem, P; Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. Journal of the American Academy of Dermatology. 58 (3): 375-381, 2008. Cited 793 times
Bianca D Lemos, Barry E Storer, Jayasri G Iyer, Jerri Linn Phillips, Christopher K Bichakjian, L Christine Fang, Timothy M Johnson, Nanette J Liegeois-Kwon, Clark C Otley, Kelly G Paulson, Merrick I Ross, Siegrid S Yu, Nathalie C Zeitouni, David R Byrd, Vernon K Sondak, Jeffrey E Gershenwald, Arthur J Sober, Paul Nghiem. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. Journal of the American Academy of Dermatology. 63(5): 751-761, 2010. Cited 506 times
Paulson, K G; Carter, J J; Johnson, L G; Cahill, K W; Iyer, J G; Schrama, D; Becker, J C; Madeleine, M M; Nghiem, P; Galloway, D A. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Research. 70(21): 8388-8397. 2010. Cited 192 times
Afanasiev, O K; Yelistratova, L; Miller, N; Nagase, K; Paulson, K; Iyer, J G; Ibrani, D; Koelle, D M; Nghiem, P. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clinical Cancer Research. 19(19): 5351-5360, 2013. Cited 149 times
Nghiem, P T; Bhatia, S; Lipson, E J; Kudchadkar, R R; Miller, N J; Annamalai, L; Berry, S; Chartash, E K; Daud, A; Fling, S P. PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. New England Journal of Medicine. 374(26): 2542-2552, 2016. Cited 763 times
View Basic Research Publications